Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$799M in Q4 2025 → $497M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Crispr Therapeutics Ag | 29.0% | Trimmed 19% | 2,608,419 | $144M |
| Vir Biotechnology Inc | 19.2% | Unchanged | 8,550,954 | $95.6M |
| Wave Life Sciences Inc | 13.6% | New | 18,245,691 | $67.5M |
| Biontech Se | 13.2% | Trimmed 25% | 668,526 | $65.7M |
| Ideaya Biosciences Inc | 10.3% | Unchanged | 1,333,333 | $51.2M |
| Cytokinetics Inc | 4.5% | Unchanged | 340,434 | $22.4M |
| Lyell Immunopharma Inc | 3.0% | Unchanged | 1,512,659 | $14.8M |
| Spero Therapeutics Inc | 2.2% | Unchanged | 9,190,606 | $11.1M |
| Nkarta Inc | 1.7% | Unchanged | 3,150,732 | $8.25M |
| Fulcrum Therapeutics Inc | 1.3% | Unchanged | 1,785,714 | $6.61M |
| Bicycle Therapeutics PLC | 1.1% | Unchanged | 1,529,561 | $5.63M |
| Regenxbio Inc | 0.4% | Unchanged | 271,456 | $2.04M |
| Cvrx Inc | 0.4% | Unchanged | 1,007,583 | $1.76M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2026 · filed November 05, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Wave Life Sciences Ltd | Exited | −18,245,691 | −$106M | — |
| Wave Life Sciences Inc | New | +18,245,691 | +$67.5M | 13.6% |
| Crispr Therapeutics Ag | Trimmed | −612,208 | −$33.9M | 29.0% |
| Biontech Se | Trimmed | −221,298 | −$21.8M | 13.2% |
quarter ended June 30, 2026 · filed August 13, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SH Senseonics Hldgs Inc | Exited | −10,856 | −$59.9K | — |
| Harvard Bioscience Inc | Exited | −11,151 | −$7.46K | — |
Loading...